Back

Impact and course of albuminuria in acute heart failure according to left or right sided heart failure phenotype

30 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: In-hospital care of acute heart failure Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Jonathan Deniz Rosario

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)

7 More presentations in this session

Presentation thumbnail
Levosimendan therapy and mortality predictors in end-stage heart failure patients beyond advanced therapeutic options
Doctor S. Jimenez-Marrero (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of urine output after catecholamine administration in cardiogenic shock due to acute decompensated heart failure
Doctor S. Kawanami (Sakai, JP)
Abstract Slides Video
Presentation thumbnail
Impact of in-hospital initiation of angiotensin receptor-neprilysin inhibition on left ventricular reverse remodeling in acute heart failure: an insight from PREMIER trial
Assistant Professor T. Takahashi (Tokushima, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic value of energetic hemodynamics in acute heart failure: beyond conventional measures
Doctor H. Chang (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Guideline directed medical treatment and comorbidity burden among patients admitted with acute HF decompensation: insights from the HECMOS 2.0
Doctor I. Leontsinis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
In-hospital care of acute heart failure

The Event

Event poster

ESC Congress 2025

30 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Albuminuria and acute heart failure. Prognostic implications and short-term mortality.
thumbnail
Congress Presentation
The role of albuminuria in acute heart failure: from admission to early post-discharge outcomes
thumbnail
Congress Presentation
Natriuretic response and diuretic exposure according to congestion phenotype

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources